ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;85:S780-S784. doi:10.1016/j.athoracsur.2007.11.063
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hiran C. Fernando
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernando, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernando, H. C.
Related Collections
Right arrow Minimally invasive surgery

Supplement: The Minimally Invasive Thoracic Surgery Summit

Radiofrequency Ablation to Treat Non-Small Cell Lung Cancer and Pulmonary Metastases

Hiran C. Fernando, MD*

Department of Cardiothoracic Surgery, Boston Medical Center, Boston University, Boston, Massachusetts

* Address correspondence to Dr Fernando, Department of Cardiothoracic Surgery, Boston Medical Center, 88 E Newton St, Robinson B402, Boston, MA 02118 (Email: hiran.Fernando{at}bmc.org).

Presented at the Minimally Invasive Thoracic Surgery Summit, New York, NY, June 8–9, 2007.

Radiofrequency ablation is being reported with increasing frequency for the treatment of lung tumors. Several studies have demonstrated that this is a feasible and safe approach. Intermediate outcomes are now becoming available. Although tumors up to 5 cm in size can be effectively treated with radiofrequency ablation, results are better for smaller tumors (3 cm or less). This review describes the techniques, available ablation devices, and the potential role of radiofrequency ablation for non-small cell lung cancer (NSCLC) and pulmonary metastases. Resection (lobar or sublobar) should remain the standard therapy for NSCLC. Radiofrequency ablation may be better than conventional external-beam radiation for the treatment of the high-risk individual with NSCLC. Preliminary results for pulmonary metastases are similar to those reported after resection. In addition, patients with pulmonary metastases have been demonstrated to develop recurrences even after thoracotomy and bimanual palpation of the lung. Radiofrequency ablation may be an alternative to resection for the patient with small-diameter pulmonary metastases, and future study of this may be indicated.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. Basile, G. Banna, S. Saita, F. Coppolino, and M. T. Patti
Is a 1-cm Margin From Major Vessels Adequate for Radiofrequency Ablation of Pulmonary Neoplasms?
Ann. Thorac. Surg., July 1, 2009; 88(1): 351 - 352.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Pennathur, G. Abbas, I. Qureshi, M. J. Schuchert, Y. Wang, S. Gilbert, R. J. Landreneau, and J. D. Luketich
Radiofrequency Ablation for the Treatment of Pulmonary Metastases
Ann. Thorac. Surg., April 1, 2009; 87(4): 1030 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Okuma, T. Matsuoka, S. Hamamoto, K. Nakamura, and Y. Inoue
Percutaneous computed tomography-guided radiofrequency ablation of lung tumors complicated with idiopathic interstitial pneumonia.
Ann. Thorac. Surg., March 1, 2009; 87(3): 948 - 950.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.